Investment Rating - Buy-A rating (首次覆盖) [1][8] Core Views - The company is a high-dividend-paying central state-owned enterprise (SOE) with a focus on differentiated products and improving profitability [2] - The "Bio+" strategy is accelerating, driving growth in high-margin biological fertilizers and capturing demand from economic crops [3] - The company has abundant phosphate ore reserves, with potential for future growth [4] Financial Performance - Revenue for the first three quarters of 2024 reached RMB 18.21 billion, with net profit of RMB 1.287 billion, a 3% YoY increase [1] - Gross margin improved from 8.66% in 2021 to 12.15% in H1 2024, while net margin increased from 3.88% to 7.77% over the same period [2] - The company's cash dividend payout ratio reached 50% in 2023, with cumulative cash dividends of RMB 1.007 billion over 2021-2023 [2] "Bio+" Strategy - The "Bio+" strategy focuses on core products like Blue Scale and Kedefeng, with new products such as the "Huanfeng" brand driving growth [3] - Revenue from the growth business reached RMB 5.555 billion in H1 2024, up 5% YoY, with pre-tax profit of RMB 398 million, a 27% YoY increase [3] - The company has completed trial production and sales of four key "Bio+" products, leveraging resources from Sinochem Group and Syngenta [3] Phosphate Ore Reserves - The company's subsidiary, Sinochem Yunlong, has nearly 200 million tons of phosphate ore reserves, with the Meizushao mining area holding 110 million tons and the Dawan mining area holding 90 million tons [4] - The Meizushao mining area has an annual production capacity of 600,000 tons of high-quality, low-silicon, low-heavy-metal phosphate ore, with significant future potential [4] Valuation and Forecast - EPS for 2024-2026 is forecasted at RMB 0.17, RMB 0.19, and RMB 0.20, respectively, with corresponding P/E ratios of 6.0x, 5.1x, and 5.0x [8] - The company's dividend yield is expected to be 8.28%, 9.65%, and 9.86% for 2024-2026, based on a 50% payout ratio [2] - Revenue is projected to grow by 14.02% in 2024, with net profit expected to increase by 85.33% YoY [10]

Financial Performance - The company achieved a net profit of RMB 1.073 billion in the first half of 2024, remaining flat year-on-year, with profit attributable to shareholders increasing by 4.68% to RMB 1.051 billion[8] - Revenue for the first half of 2024 reached RMB 13.681 billion, with a net profit attributable to shareholders of RMB 1.051 billion, a year-on-year increase of 4.68%[19] - Revenue for the six months ended June 30, 2024, reached RMB 13,680,872 thousand, a 4.2% increase compared to RMB 13,127,927 thousand in the same period of 2023[80] - Gross profit for the first half of 2024 was RMB 1,662,576 thousand, up 7.2% from RMB 1,550,255 thousand in the first half of 2023[80] - Operating profit for the six months ended June 30, 2024, was RMB 1,117,712 thousand, a 2.5% increase from RMB 1,090,885 thousand in the same period of 2023[80] - Net profit attributable to shareholders for the first half of 2024 was RMB 1,050,926 thousand, a 4.7% increase compared to RMB 1,003,919 thousand in the first half of 2023[80] - Basic and diluted earnings per share for the six months ended June 30, 2024, were RMB 0.1496, up 4.7% from RMB 0.1429 in the same period of 2023[81] - The company's comprehensive income for the six months ended June 30, 2024, was RMB 996,584 thousand, a 7.2% decrease compared to RMB 1,073,659 thousand in the same period of 2023[81] - Total revenue for the six months ended June 30, 2024, was RMB 13,680,872 thousand, compared to RMB 13,127,927 thousand for the same period in 2023, representing a 4.2% increase[93][94] - Segment profit for the six months ended June 30, 2024, was RMB 1,223,944 thousand, up 1.6% from RMB 1,205,195 thousand in the same period in 2023[93][94] - Profit before tax for the six months ended June 30, 2024, was RMB 1,238,609 thousand, a 7.2% increase from RMB 1,155,414 thousand in the same period in 2023[93][94] - The company's income tax expense for the six months ended June 30, 2024, was RMB 166,017 thousand, a 97.6% increase from RMB 83,995 thousand in the same period in 2023[100] - Basic earnings per share for the six months ended June 30, 2024, were RMB 1,050,926 thousand, a 4.7% increase from RMB 1,003,919 thousand in the same period in 2023[102] Business Segments and Product Performance - The growth business segment generated revenue of RMB 5.555 billion, a 5% year-on-year increase, with pre-tax profit reaching RMB 398 million, up 27% year-on-year[8] - The production segment achieved a pre-tax profit of RMB 357 million in the first half of 2024, remaining flat year-on-year[8] - The company's basic business achieved revenue of RMB 6.878 billion in the first half of the year, an increase of RMB 410 million year-on-year, with a pre-tax profit of RMB 469 million, down 12% due to price declines[9] - Sales of bio-phosphate fertilizers increased by 10% year-on-year, driving growth in the basic business[9] - The company launched its first bio-integrated potassium fertilizer product, "Weidefeng," nationwide, enhancing potassium fertilizer efficiency[15] - The company's subsidiary, Sinochem Fuling, successfully produced qualified bio-phosphate fertilizer products under the brand "Linbao"[12] - The company introduced the "Huanfeng®" brand, a full-nutrient crop-specific fertilizer, integrating multiple advanced technologies developed by Syngenta Group China[13] - The company achieved a pre-tax profit of RMB 81.6694 million at Zhonghua Fuling, with a phosphate plant capacity utilization rate of 106.38%[20] - Zhonghua Yunlong produced 182,100 tons of feed calcium and achieved a pre-tax profit of RMB 241.28 million, an increase of RMB 4.0963 million year-on-year[21] - Zhonghua Changshan achieved a pre-tax profit of RMB 42.2 million, a decrease of RMB 21.37 million year-on-year due to low market prices for synthetic ammonia and urea[21] - The company successfully produced differentiated phosphate fertilizer products "Linbao" and "Meilinmei"[21] - The company's R&D achievements were transformed into 886,000 tons of products in the first half of 2024[19] - The company's differentiated compound fertilizer sales reached 1.1 million tons, a year-on-year increase of 14.62%[25] - The "Bio+" high-end product sales increased by 65% year-on-year[25] - The special fertilizer business achieved revenue of RMB 444 million, a year-on-year increase of 23.28%[26] - The total production capacity of the special fertilizer business reached 185,000 tons[26] - The sales of key "Double Excellence" products in the special fertilizer business increased by 50% year-on-year[26] - The company achieved plant protection synergy revenue of RMB 240 million, with a three-year compound growth rate of 21%[27] - The seed synergy revenue reached RMB 33.96 million, with nearly 60 synergistic varieties sold across crops such as rice, corn, vegetables, and wheat[27] - Sales volume for the first half of 2024 reached 4.66 million tons, a 17.38% increase compared to the same period in 2023[34] - Revenue for the first half of 2024 was RMB 13.681 billion, a 4.21% increase year-over-year[34] - Gross profit for the first half of 2024 was RMB 1.663 billion, up 7.29% compared to the same period in 2023[34] - Net profit attributable to shareholders for the first half of 2024 was RMB 1.051 billion, a 4.68% increase year-over-year[34] - The company's differentiated product sales reached 1.32 million tons in the first half of 2024, a 14.56% increase year-over-year[35] - Sales of differentiated compound fertilizers reached 1.1 million tons in the first half of 2024, a 14.62% increase compared to the same period in 2023[35] - Revenue from compound fertilizers increased to RMB 4,691,743 thousand in the six months ended June 30, 2024, from RMB 4,528,876 thousand in the same period of 2023[91] - Revenue from phosphate fertilizers rose to RMB 4,175,840 thousand in the six months ended June 30, 2024, from RMB 3,475,313 thousand in the same period of 2023[91] - Revenue from potash fertilizers decreased to RMB 2,507,905 thousand in the six months ended June 30, 2024, from RMB 2,872,389 thousand in the same period of 2023[91] - Revenue from special fertilizers increased to RMB 443,668 thousand in the six months ended June 30, 2024, from RMB 359,881 thousand in the same period of 2023[91] - Total revenue from customer contracts was RMB 13,680,872 thousand in the six months ended June 30, 2024, compared to RMB 13,127,927 thousand in the same period of 2023[91] - Revenue from Mainland China accounted for RMB 13,114,553 thousand in the six months ended June 30, 2024, up from RMB 12,611,224 thousand in the same period of 2023[91] R&D and Innovation - The company launched a new "Bio+" product, the "Huanfeng®" brand, integrating advanced technologies from Syngenta Group China[8] - The company completed the trial production and sales of 4 key products under the "Bio+" strategy, including "Bio+" organic-inorganic fertilizer - Huanfeng and "Bio+" carbohydrate-soluble fertilizer - Shuidifeng[9] - The company obtained 48 authorized invention patents, with 23 in the field of biotechnology, supporting the "Bio+" strategy[9] - R&D achievements were converted into 886,000 tons of products, a year-on-year increase of 17.2%[9] - The company launched the "Weidefeng" series of potassium sulfate products to enhance terminal agricultural technical services[23] - The company plans to focus on the "Bio+" strategy, aiming to enhance R&D capabilities and increase investment in new bio-fertilizer technologies[33] Operational Efficiency and Management - The company implemented 24 actions across subsidiaries to enhance production management and operational efficiency[8] - The company's production capacity utilization rate remained at a relatively high level within the industry[8] - The company focused on optimizing its product structure, driving high growth in key products such as "Blue Scale" and "Kedefeng"[8] - The company conducted benchmarking studies with leading companies to strengthen production management practices[8] - The company maintained strict safety production and internal control management, ensuring stable operations[8] - The company utilized 686,000 tons of phosphogypsum, achieving a comprehensive utilization rate of 100%[21] - The company conducted over 30,000 comprehensive technical service activities, benefiting over 1.4 million farmers[28] - The company's digital marketing activities reached over 5 million online users and covered over 300,000 farmers through offline promotion meetings[29] - The company conducted over 30,000 technical service activities and established more than 1,500 demonstration fields in the first half of 2024[32] - The company provided direct benefits to over 4 million farmers through various agricultural support initiatives in the first half of 2024[32] - The company launched the "Houpu Soil Health +" service platform, which has developed 18 sets of soil health indicators and solutions[32] - The company employed approximately 4,379 full-time employees as of June 30, 2024, with compensation benchmarked against market levels[76] - The company conducted training for 4,245 employees, totaling 28,865 training hours in the first half of 2024[76] Financial Position and Liquidity - The company's cash and cash equivalents as of June 30, 2024, amounted to RMB 3.762 billion, primarily held in RMB and USD[61] - The company's total interest-bearing liabilities as of June 30, 2024, were RMB 1.810 billion, compared to RMB 1.829 billion as of December 31, 2023[62] - The company has obtained bank credit facilities equivalent to RMB 24.204 billion, including USD 759 million and RMB 18.792 billion, with unused credit facilities of RMB 21.214 billion, including USD 728 million and RMB 16.020 billion[64] - The company plans to repay its loans using internal resources[65] - The company manages liquidity risk by strengthening daily cash management, forecasting and executing capital plans, and maintaining sufficient cash and cash equivalents[72] - Total non-current assets increased to RMB 8,820,810 thousand as of June 30, 2024, compared to RMB 7,854,561 thousand as of December 31, 2023[82] - Current assets decreased to RMB 11,137,535 thousand as of June 30, 2024, from RMB 14,128,340 thousand as of December 31, 2023[82] - Inventory decreased significantly to RMB 3,418,501 thousand as of June 30, 2024, from RMB 5,683,619 thousand as of December 31, 2023[82] - Trade receivables and bills increased to RMB 723,065 thousand as of June 30, 2024, from RMB 469,532 thousand as of December 31, 2023[82] - Total current liabilities decreased to RMB 8,006,169 thousand as of June 30, 2024, from RMB 10,631,821 thousand as of December 31, 2023[84] - Net current assets stood at RMB 3,131,366 thousand as of June 30, 2024, compared to RMB 3,496,519 thousand as of December 31, 2023[84] - Total equity increased to RMB 10,608,577 thousand as of June 30, 2024, from RMB 9,918,784 thousand as of December 31, 2023[84] - Profit attributable to shareholders for the period was RMB 1,050,926 thousand as of June 30, 2024[85] - Other comprehensive income for the period was a loss of RMB 76,008 thousand as of June 30, 2024[85] - Total comprehensive income for the period was RMB 974,918 thousand as of June 30, 2024[85] - Operating cash inflow for the six months ended June 30, 2024, was RMB 1,212,486 thousand, slightly lower than RMB 1,214,638 thousand in the same period of 2023[86] - Investment cash outflow for the six months ended June 30, 2024, was RMB 1,275,005 thousand, compared to RMB 984,324 thousand in the same period of 2023[86] - Cash and cash equivalents decreased by RMB 146,756 thousand in the six months ended June 30, 2024, compared to an increase of RMB 234,363 thousand in the same period of 2023[87] - The company's financing costs for the six months ended June 30, 2024, were RMB 31,419 thousand, a 13.6% decrease from RMB 36,365 thousand in the same period in 2023[96] - Depreciation expenses for the six months ended June 30, 2024, were RMB 169,263 thousand for owned property, plant, and equipment, and RMB 15,414 thousand for right-of-use assets[97] - The company acquired property, plant, and equipment with an original value of RMB 243,692 thousand during the six months ended June 30, 2024, a 37.7% decrease from RMB 391,296 thousand in the same period in 2023[103] - No impairment loss was recognized for the six months ended June 30, 2024 (same period in 2023: none)[104] - Goodwill as of June 30, 2024, was RMB 856,454 thousand, compared to RMB 854,137 thousand as of December 31, 2023[105] - Trade receivables and notes, net of impairment allowance, totaled RMB 723,065 thousand as of June 30, 2024, up from RMB 469,532 thousand as of December 31, 2023[107] - Trade payables and notes amounted to RMB 3,435,510 thousand as of June 30, 2024, down from RMB 3,771,752 thousand as of December 31, 2023[109] - Bank and other borrowings totaled RMB 1,741,974 thousand as of June 30, 2024, compared to RMB 1,788,858 thousand as of December 31, 2023[112] - The effective annual interest rate for variable-rate borrowings was 3.00% as of June 30, 2024, down from 3.35% as of December 31, 2023[115] - The company did not declare an interim dividend for the six months ended June 30, 2024 (same period in 2023: none)[116] - The dividend per share for the previous financial year was HKD 0.0491 (same period in 2023: HKD 0.0623)[117] - The fair value of non-listed securities as of June 30, 2024, was RMB 46,142 thousand, classified under Level 3 of the fair value hierarchy[119] - The fair value of accounts receivable (notes) as of June 30, 2024, was RMB 43,968 thousand, also classified under Level 3 of the fair value hierarchy[119] - The fair value of forward foreign exchange contracts under Level 2 was RMB (21,810) thousand as of June 30, 2024[119] - The total fair value of financial instruments classified under Level 3 as of June 30, 2024, was RMB 90,110 thousand[119] - The fair value of non-listed securities decreased by RMB 118,211 thousand during the six months ended June 30, 2024[124] - The fair value of accounts receivable (notes) decreased by RMB 25,154 thousand during the six months ended June 30, 2024[124] - The company's capital commitments for property, plant, and equipment as of June 30, 2024, amounted to RMB 41,506 thousand[126] - The fair value of non-listed securities as of December 31, 2023, was RMB 164,353 thousand, classified under Level 3[120] - The fair value of accounts receivable (notes) as of December 31, 2023, was RMB 69,122 thousand, classified under Level 3[120] - The total fair value of financial instruments classified under Level 3 as of December 31, 2023, was RMB 233,475 thousand[120] - The company repaid a loan of RMB 11.46 million to a subsidiary of its ultimate holding company in 2024[132] - The company provided financial guarantees to an associate amounting to RMB 478.70 million in 2023[132] - The company loaned RMB 167.67 million to an associate in 2024 with an annual interest rate based on the one-year loan market quotation rate[135] - The company's cash and cash equivalents stood at RMB 732.89 million as of June 30, 2023[134] Market and Industry Trends - The company's fertilizer product prices showed a "V" trend, with prices recovering in April and exceeding the previous year's levels by June[8] - Fertilizer imports increased by 20.0% to 7.27 million tons, while exports decreased by 4

Investment Rating - The report maintains a **Buy** rating for Sinochem Fertilizer (297 HK) with a target price of **HKD 1 4**, representing a **49% upside** from the current price of HKD 0 94 [1][4] Core Views - Sinochem Fertilizer's H1 2024 net profit attributable to shareholders grew by **4 7% YoY to RMB 1 05 billion**, exceeding expectations [1][2] - The company's revenue in H1 2024 reached **RMB 13 68 billion**, up **4 2% YoY**, driven by improved product mix and operational efficiency [2] - The **Bio+ strategy** is showing significant results, with differentiated product sales reaching **1 32 million tons**, up **14 6% YoY** [2] - The report raises the company's net profit forecasts for 2024-2026 to **RMB 1 09/1 18/1 28 billion**, representing a **74%/8%/8% YoY growth** respectively [1][2] Financial Performance Revenue and Profit - H1 2024 revenue: **RMB 13 68 billion**, up **4 2% YoY** [2] - H1 2024 net profit attributable to shareholders: **RMB 1 05 billion**, up **4 7% YoY** [2] - 2024E-2026E revenue growth: **6%/5%/6%** [3][9] - 2024E-2026E net profit growth: **74%/8%/8%** [3][9] Product Sales - Total fertilizer sales in H1 2024: **4 66 million tons**, up **17% YoY** [2] - Compound fertilizer revenue: **RMB 4 69 billion**, up **4% YoY** [2] - Phosphate fertilizer revenue: **RMB 4 18 billion**, up **20% YoY** [2] - Potassium fertilizer revenue: **RMB 2 51 billion**, down **13% YoY** [2] - Special fertilizer revenue: **RMB 440 million**, up **23% YoY** [2] Profitability - 2024E-2026E gross margin: **11%/11%/11%** [3][9] - 2024E-2026E net margin: **5%/5%/5%** [3][9] - 2024E-2026E ROE: **5%/6%/6%** [9] Strategic Initiatives - The **Bio+ strategy** is driving growth, with differentiated product sales reaching **1 32 million tons**, up **14 6% YoY** [2] - Key new products such as **Huanfeng**, **Weidefeng**, and **Shuifeng** have been launched, gaining market recognition for their quality and functionality [2] - The company plans to increase R&D investment in **Bio+ fertilizers** and develop large-scale biological products to further boost performance [2] Valuation and Market Performance - Target price: **HKD 1 4**, based on **8 3x 2024E P/E** [1][4] - Current price (as of 2024-08-26): **HKD 0 94** [4] - Market cap: **HKD 6 6 billion** [5] - 12-month price range: **HKD 0 7-1 1** [5] Financial Forecasts Income Statement - 2024E-2026E revenue: **RMB 23 06/24 31/25 71 billion** [8] - 2024E-2026E net profit: **RMB 1 09/1 18/1 28 billion** [8] Balance Sheet - 2024E-2026E total assets: **RMB 20 51/21 23/22 07 billion** [10] - 2024E-2026E equity: **RMB 10 74/11 42/12 16 billion** [10] Cash Flow - 2024E-2026E operating cash flow: **RMB 1 48/1 71/1 81 billion** [11] - 2024E-2026E net cash change: **RMB 550/444/159 million** [11]

研究报告 Research Report 27 Aug 2024 中化化肥 Sinofert Holdings (297 HK) 首次覆盖：2024H1 扣非后净利润同比增长 4.68%，成长业务高速增长 Recurring Net Profit up 4.68% in2024H1; Growth Segment Grows Rapidly: Initiation | --- | --- | |-------------------------------------------------------------|--------------------------| | [Table_Info] 首次覆盖优于大市 | Initiate with OUTPERFORM | | 评级 | 优于大市 OUTPERFORM | | 现价 | HK$0.94 | | 目标价 | HK$1.27 | | HTI ESG | 4.1-5.0-5.0 | | E-S-G: 0-5, (Please refer to the Appendix for ESG comments) | | | 市值 | HK$6.60bn / ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不會就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 （於百慕達註冊成立之有限公司） （股份代號：297） 中期業績公告 截至二零二四年六月三十日止六個月 | --- | |----------------------------------------------------------------| | | | 財務摘要 | | ‧ 本期本集團營業額人民幣 136.81 億元，同比增長 4.21% | | ‧ 本期本公司股東應佔溢利人民幣 10.51 億元，同比增長 4.68% | | ‧ 本期每股基本盈利人民幣 0.1496 元，同比增長 4.68% | | ‧ 董事會建議不宣派截至二零二四年六月三十日止六個月的中期股息 | 1 主席致辭 尊敬的各位股東： 本人謹代表全體董事向各位股東報告中化化肥控股有限公司（「本公司」）及附屬公司（「本集團」）截至二 零二四年六月三十日止六個 ...

2024 年 08 月 12 日 中化化肥（297.HK） 化肥行业"国家队" ，大力发展农业新质生产力 中化化肥的业务是向用户提供化肥产品和农化服务。按照规模计算，中化化肥是中国大 型化肥进口商，拥有超过 30 年的化肥国际贸易经验和国际贸易关系。是中国领先的化 肥分销商，拥有庞大的分销服务网络，农业县覆盖 2200 个、农业乡镇覆盖 1.8 万个、 乡镇门店 4 万多家，覆盖中国 95%农业耕地的分销服务网络和仓储物流网络。近年来， 中化化肥聚焦生物肥料，依托中国中化和先正达集团的雄厚实力和科技资源，研发并推 出新一代生物+系列产品，目标成为生物肥料和土壤健康的创新引领者。我们看好中化 化肥强大的央企背景，化肥研、采、产、销一体化持续贡献良好收益和稳定的现金流。 生物肥作为新兴业务，发展空间巨大。我们给予中化化肥目标价 1.40 港元，对应 2024 财年预测 PE 倍数 10.8 倍，距离现价有 52%上升空间，首次评级买入。 报告摘要 化肥行业中的"国家队"。中化化肥在国际化肥市场上具有重要影响力，是国际肥 料工业协会（IFA）会员单位、国际植物营养研究所（IPNI）全球 17 家理事单位之 一。中化 ...

中化化肥控股有限公司 SINOFERT HOLDINGS LIMITED (於E#建註冊成立2有限公司) 股f號 : 20 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------|-------|-------|-------|-------|-------|-------|-------|----------|-------| | | | | | | | | | | | | | | | | | | | | | | | 與中國 | | | | | | | | | | | 現代農業 | | | | | | | | | | | 共同成長 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 年度報告 | | | | | | | | | | | 2023 | | 目 錄 | --- | --- | --- | |-------|-------|--------------- ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 （於百慕達註冊成立之有限公司） （股份代號：297） 年度業績公告 截至二零二三年十二月三十一日止年度 | --- | --- | |-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 財務摘要 | | ‧ | 本年度本集團營業額為人民幣 217.28 億元（二零二二年：人民幣 230.03 億元），同比減少 5.54% | | ‧ | 本年度本公司股東應佔溢利為人民幣 6.26 億元（二零二二年：人民幣 ...

中 期 報 告 2023 中期報告INTERIM REPORT 與中國現代農業 2023 共同成長 目 錄 釋義 2 公司資料 5 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不會就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 （於百慕達註冊成立之有限公司） （股份代號：297） 中期業績公告 截至二零二三年六月三十日止六個月 | --- | |----------------------------------------------------------------| | | | 財務摘要 | | ‧ 本期本集團營業額人民幣 131.28 億元 | | ‧ 本期本公司股東應佔溢利人民幣 10.04 億元，同比增長 0.6% | | ‧ 本期每股基本盈利人民幣 0.1429 元，同比增長 0.6% | | ‧ 董事會建議不宣派截至二零二三年六月三十日止六個月的中期股息 | 1 主席致辭 尊敬的各位股東： 本人僅代表全體董事向各位股東報告本集團截至二零二三年六月三十日止六個月的中期業績情況。 二零二三年上半年，隨著全球供應鏈緊張情況緩解和化肥產能的逐步 ...